Product

Promising Screening in a Challenging Disease Area

Alzheimer's Disease is a devastating, irreversible, progressive brain disorder that slowly destroys memory, cognition, and eventually the ability to complete simple tasks. As the 6th leading cause of death in the United States, it is one of the most expensive diseases, costing close to $259 billion dollars annually in the US. Alzheimer’s disease biology can manifest in the brain up to 10 years prior to patient symptoms, however due to the cost-prohibitive and resource intensive nature of diagnosis, Alzheimer’s disease screening is not routine. Our innovative device moves away from costly neuroimaging diagnostic techniques and qualitative methods of diagnosis to a more robust, affordable, and accessible mode of analysis, a portable Electroencephalogram (EEG) + Artificial Intelligence system.